Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07837986
NA

Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies

Sponsor: Hospices Civils de Lyon

View on ClinicalTrials.gov

Summary

Systemic autoimmune diseases associated with type I interferon (IFN-I) dysregulation, such as systemic lupus erythematosus, systemic sclerosis, myositis, and mixed or undifferentiated connective tissue diseases, and genetic type 1 interferonopathies are characterized by chronic and excession IFN-I signaling and production contributing to disease pathogenesis. Aberrant IFN-I production can be triggered through the activation of multiple signaling pathways, particularly those involving intracellular and extracellular RNA and DNA sensing receptors. We hypothesize that excessive IFN-I production results from an increased tonic activation state of nucleic acid sensors and/or an enhanced responsiveness of these sensors to endogenous nucleic acids, thereby sustaining pathological IFN-I signaling and chronic inflammation. The aim of this study is to characterize the type I interferon (IFN-I) response, defined by both the IFN-I gene signature and plasma IFN-α levels, following stimulation with a panel of ligands specific for DNA- and RNA-sensing pathways.

Official title: Type I Interferon Excess in Autoimmune Diseases and Genetic Type I Interferonopathies

Key Details

Gender

All

Age Range

6 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-12-01

Completion Date

2033-01-01

Last Updated

2026-09-24

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

biological samples

Healthy volunteers will undergo a blood draw of a total volume of 20 mL for the following analyses: ex vivo analysis of the interferon signaling pathway (12 mL) and biological sample collection, if the patient/holder of parental authority provides consent (8 mL).

Locations (3)

Hôpital Femme-Mère-Enfant

Bron, France

Hôpital Edouard Herriot

Lyon, France

Centre Hospitalier Lyon-Sud

Oullins, France